S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research.
about
S-Adenosylmethionine and Superoxide Dismutase 1 Synergistically Counteract Alzheimer's Disease Features Progression in TgCRND8 Mice.Mitochondrial Agents for Bipolar Disorder.Blood and urinary metabolomic evidence validating traditional Chinese medicine diagnostic classification of major depressive disorder
P2860
S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
S-Adenosylmethionine (SAMe) fo ...... n-Oriented Review of Research.
@en
type
label
S-Adenosylmethionine (SAMe) fo ...... n-Oriented Review of Research.
@en
prefLabel
S-Adenosylmethionine (SAMe) fo ...... n-Oriented Review of Research.
@en
P2093
P2860
P356
P1476
S-Adenosylmethionine (SAMe) fo ...... n-Oriented Review of Research.
@en
P2093
Anup Sharma
David Mischoulon
Lila Massoumi
Linda L Carpenter
Patricia Gerbarg
Philip R Muskin
Richard P Brown
Teodoro Bottiglieri
as Work Group of the American Psychiatric Association Council on Research
P2860
P304
P356
10.4088/JCP.16R11113
P577
2017-06-01T00:00:00Z